Event Details

XBiotech Inc at the 26th EADV Congress

14 Sep '2017 2:00 PM CEST

Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa will be presented.

Location

Geneva, Switzerland
xbiotech logo